Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Post-Surgical Pain

FDA to Review Resubmitted NDA for Postoperative Pain Management

Diana Ernst, RPh

October 29, 2019

HTX-011 is a dual-acting, fixed-dose combination of bupivacaine and meloxicam.

Migraine & Headache

Reyvow Approved for Acute Migraine Treatment

Diana Ernst, RPh

October 18, 2019

The FDA has approved Reyvow for the acute treatment of migraine with or without aura in adults.

General Pain

Methemoglobinemia Following Overuse of OTC Topical Pain Reliever

Diana Ernst, RPh

October 1, 2019

A report published in the New England Journal of Medicine describes the case of a 25-year-old woman who developed methemoglobinemia following the use of topical benzocaine.

Chronic Pain

FDA Approves First-in-Class Treatment for IBS-C

Diana Ernst, RPh

September 17, 2019

Ibsrela is a sodium/hydrogen exchanger 3 (NHE3) inhibitor.

Opioid Addiction

DEA Proposes Less Opioid Production, More Marijuana for Research in 2020

Diana Ernst, RPh

September 16, 2019

Cuts are being proposed for 5 controlled substances based on estimates of diversion.

Practice Management

CDC: Updated Influenza Vaccination Recommendations for 2019-2020

Diana Ernst, RPh

September 10, 2019

The 2019-2020 composition includes updates in the influenza A(H1N1)pdm09 and influenza A(H3N2) components of the vaccine.

Practice Management

Do US Adults Use More Prescription Drugs Than Canadians?

Diana Ernst, RPh

August 26, 2019

Prescription drug use appears to be similar in the US and Canada, according to a new data brief from the Centers for Disease Control and Prevention (CDC).

Next post in Practice Management